Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlobiFer International is a Belgian pharmaceutical company specializing in the development and commercialization of advanced iron supplements based on heme iron polypeptide (HIP) technology. The company's product portfolio, including GlobiFer Forte and GlobiFer Plus, is designed to address iron deficiency and anemia by providing superior absorption with significantly fewer gastrointestinal side effects compared to traditional synthetic iron salts. By utilizing natural heme iron, these formulations leverage the body's physiological heme-specific absorption pathways, making them an ideal solution for patients with sensitive stomachs or chronic conditions. GlobiFer operates through an extensive global distribution network, catering to therapeutic areas such as women's health, nephrology, and sports medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlobiFer International.